ARCHIVES

NSABP “Saddened” But Some Patient Advocates Hail “Courageous” Decision.

This article is from The Cancer Letter archive.

Vol. 33 No. 24 | June 22, 2007

Download PDF Visit The Full Archive

Related Articles

FDA Approves Velcade Injection In Mantle Cell Lymphoma

October 31, 2014

Armand Hammer Panel chairman; DeVita Announces Greenwald Appointment; Adamson To Be DCCP Director

October 9, 1981

NIH Should Review CRADA Pricing, Wyden Write to Shalala

February 5, 1993

DCBDC Advisors Set aside $2 Mil. For Research On The Microenvironment of Breast Cancer

July 9, 1993

ASCO Seeks “Nothing Less Than A Smoke-Free World”

June 6, 2003

Bristol Stock Drops Amid New Setbacks, Deepening Firm’s Decline In Oncology

April 5, 2002